Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US69329Y1047
Ticker PDLI
Company PDL BIOPHARMA
Currency $
Price
Aware Investor Index (AII) 98.5965
Recommendation STRONG BUY
P/E 2.32
ROE 21.98 %
Capitalization 354,912,180 $
Dividend Yield 27.65 %
P/S 0.60
AII Position 40
P/E Position 2
ROE Position 141
Capitalization Position 777
Dividend Yield Position 2
Sales 590,448,000 $
10-Year Average Earnings 152,946,700 $
Shares Outstanding 163,554,000
Equity 695,952,000 $
Dividend per Share 0.6 $
Industry Biotechnology
Country United States
PDL BIOPHARMA Investor Relations Web Site http://investor.pdl.com







Sales:

YEAR MONTH AMOUNT
2015 12 590,448,000.00 $
2014 12 581,225,000.00 $
2013 12 442,921,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 332,795,000.00 $
2014 12 322,244,000.00 $
2013 12 264,530,000.00 $
2012 12 211,669,000.00 $
2011 12 199,389,000.00 $
2010 12 91,874,000.00 $
2009 12 189,660,000.00 $
2008 12 68,387,000.00 $
2007 12 -21,061,000.00 $
2006 12 -130,020,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 695,952,000.00 $
2014 12 460,437,000.00 $
2013 12 113,489,000.00 $
2012 12 -68,122,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 163,554,000
2014 12 173,110,000
2013 12 159,343,000
2012 12 146,403,000

 












Bloomberg News for PDL BIOPHARMA:



Google News for PDL BIOPHARMA:

Hillary HQ (press release) - 3 days ago
EPS for DMC Global Inc. (BOOM) Expected At $0.42; Pdl Biopharma ...
Pdl Biopharma Inc (NASDAQ:PDLI) had an increase of 0.07% in short interest. PDLI's SI was 16.65M shares in July as released by FINRA.
Stocks News Point (satire) (press release) (blog)
$0.06 EPS Expected for PDL BioPharma, Inc. (PDLI); Verisign ...
Analysts expect PDL BioPharma, Inc. (NASDAQ:PDLI) to report $0.06 EPS on August, 2.They anticipate $0.20 EPS change or 76.92% from last ...
Baseball Daily Digest
Obalon Therapeutics, Inc. (OBLN) EPS Estimated At $-0.50; PDL ...
PDL Biopharma Inc (PDLI) investors sentiment decreased to 0.78 in Q1 2018. It's down -0.35, from 1.13 in 2017Q4. The ratio fall, as 58 funds ...
The Cardinal Weekly (press release)
Stock to Watch: Pdl Biopharma Inc (PDLI)
Pdl Biopharma Inc (NASDAQ:PDLI) down -1.16% to close at the price of $2.56. The stock has a market capitalization of $378.16 Million ...
Hillary HQ (press release) - 2 days ago
Is PDL BioPharma (PDLI) a Great Stock for Value Investors?
If anything, PDLI is in the lower end of its range in the time period from a ... Though PDL BioPharma might be a good choice for value investors, ...
NMSU Nеws
$0.06 EPS Expected for PDL BioPharma, Inc. (PDLI); J Goldman ...
Analysts expect PDL BioPharma, Inc. (NASDAQ:PDLI) to report $0.06 EPS on August, 2.They anticipate $0.20 EPS change or 76.92% from last ...
The Cardinal Weekly (press release)
Could generate strong returns? ConocoPhillips (COP), PDL ...
ConocoPhillips (COP), PDL BioPharma, Inc. (PDLI) ... The current market cap of PDL BioPharma, Inc. is valued at $384.10M. The value there ...
TopChronicle
Hot Stock Analysis – PDL BioPharma Inc (NASDAQ: PDLI)
Investors rushed to trade on PDL BioPharma Inc (NASDAQ: PDLI) Monday, soon after a drastic change of -1.16% in the share price was ...
Flecha 123 (press release) - 14 hours ago
PDL BioPharma, Inc. (PDLI) Analysts See $0.06 EPS; 1 Analysts ...
Analysts expect PDL BioPharma, Inc. (NASDAQ:PDLI) to report $0.06 EPS on August, 2.They anticipate $0.20 EPS change or 76.92% from last ...
Emn News - 1 day ago
Comparing Ultra Petroleum Corp. (UPL) and PDL BioPharma, Inc ...
PDL BioPharma, Inc. (NASDAQ:PDLI), on the other hand, is down -5.47% year to date as of 07/13/2018. It currently trades at $2.59 and has ...


Back